These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 20005392
1. Prolonged cardiac allograft survival in mouse model after complement depletion with Yunnan cobra venom factor. Wu W, Wang HD, Zhu XX, Lan G, Yang K. Transplant Proc; 2009 Dec; 41(10):4321-7. PubMed ID: 20005392 [Abstract] [Full Text] [Related]
2. [Effect of Yunnan-cobra venom factor in overcoming acute humoral rejection after allograft cardiac transplantation in presensitized recipients: experiment with rats]. Li R, Chen G, Guo H, Wang DW, Xie L, Wang SS, Wang WY, Xiong YL, Chen S. Zhonghua Yi Xue Za Zhi; 2006 Jun 06; 86(21):1460-3. PubMed ID: 16842697 [Abstract] [Full Text] [Related]
3. Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy. Li R, Chen G, Guo H, Wang DW, Xie L, Wang SS, Wang WY, Xiong YL, Chen S. Transplant Proc; 2006 Dec 06; 38(10):3263-5. PubMed ID: 17175243 [Abstract] [Full Text] [Related]
4. Complement depletion with cobra venom factor delays acute cell-mediated rejection in pig-to-mouse corneal xenotransplantation. Oh JY, Kim MK, Lee HJ, Ko JH, Kim Y, Park CS, Kang HJ, Park CG, Kim SJ, Lee JH, Wee WR. Xenotransplantation; 2010 Dec 06; 17(2):140-6. PubMed ID: 20522246 [Abstract] [Full Text] [Related]
5. Prolongation of cardiac xenograft survival by depletion of complement. Leventhal JR, Dalmasso AP, Cromwell JW, Platt JL, Manivel CJ, Bolman RM, Matas AJ. Transplantation; 1993 Apr 06; 55(4):857-65; discussion 865-6. PubMed ID: 8475561 [Abstract] [Full Text] [Related]
6. Inhibition of the membrane attack complex of complement for induction of accommodation in the hamster-to-rat heart transplant model. Suhr BD, Black SM, Guzman-Paz M, Matas AJ, Dalmasso AP. Xenotransplantation; 2007 Nov 06; 14(6):572-9. PubMed ID: 17991145 [Abstract] [Full Text] [Related]
7. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL. Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596 [Abstract] [Full Text] [Related]
8. Rejection of cardiac xenografts by CD4+ or CD8+ T cells. Lin Y, Soares MP, Sato K, Takigami K, Csizmadia E, Anrather J, Bach FH. J Immunol; 1999 Jan 15; 162(2):1206-14. PubMed ID: 9916754 [Abstract] [Full Text] [Related]
9. Experiments in cardiac xenotransplantation. Response to intrathymic xenogeneic cells and intravenous cobra venom factor. Mohiuddin M, Kline G, Shen Z, Ruggiero V, Rostami S, DiSesa VJ. J Thorac Cardiovasc Surg; 1993 Oct 15; 106(4):632-5. PubMed ID: 8412256 [Abstract] [Full Text] [Related]
10. Improved suppression of circulating complement does not block acute vascular rejection of pig-to-rhesus monkey cardiac transplants. Chen G, Sun QY, Wang XM, Shen SQ, Guo H, Wang H, Wu Y, Wang WY, Xiong YL, Chen S. Xenotransplantation; 2004 Mar 15; 11(2):123-32. PubMed ID: 14962274 [Abstract] [Full Text] [Related]
11. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Candinas D, Lesnikoski BA, Robson SC, Miyatake T, Scesney SM, Marsh HC, Ryan US, Dalmasso AP, Hancock WW, Bach FH. Transplantation; 1996 Aug 15; 62(3):336-42. PubMed ID: 8779679 [Abstract] [Full Text] [Related]
12. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation. Chen D, Cao R, Guo H, Chen G, Wang X, Shen S, Chen S. Transplant Proc; 2004 Oct 15; 36(8):2480-2. PubMed ID: 15561288 [Abstract] [Full Text] [Related]
13. Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets. Fryer JP, Leventhal JR, Dalmasso AP, Chen S, Simone PA, Goswitz JJ, Reinsmoen NL, Matas AJ. Transplantation; 1995 Jan 27; 59(2):171-6. PubMed ID: 7839436 [Abstract] [Full Text] [Related]
14. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. Miyatake T, Sato K, Takigami K, Koyamada N, Hancock WW, Bazin H, Latinne D, Bach FH, Soares MP. J Immunol; 1998 Apr 15; 160(8):4114-23. PubMed ID: 9558123 [Abstract] [Full Text] [Related]
15. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient. Kang HJ, Lee G, Kim JY, Lee SH, Wi HC, Hwang PG, Chung DH, Kim YT. Eur J Cardiothorac Surg; 2005 Jul 15; 28(1):149-56. PubMed ID: 15982598 [Abstract] [Full Text] [Related]
16. Role of antibody synthesis and complement activation in concordant xenograft retransplantation. Gannedahl G, Karlsson-Parra A, Wallgren A, Roos-Engstrand E, Nilsson B, Tötterman TH, Tufveson G. Transplantation; 1994 Aug 15; 58(3):337-44. PubMed ID: 8053058 [Abstract] [Full Text] [Related]
17. Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model. Oberholzer J, Yu D, Triponez F, Cretin N, Andereggen E, Mentha G, White D, Buehler L, Morel P, Lou J. Immunology; 1999 May 15; 97(1):173-80. PubMed ID: 10447729 [Abstract] [Full Text] [Related]
18. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Kobayashi T, Taniguchi S, Neethling FA, Rose AG, Hancock WW, Ye Y, Niekrasz M, Kosanke S, Wright LJ, White DJ, Cooper DK. Transplantation; 1997 Nov 15; 64(9):1255-61. PubMed ID: 9371665 [Abstract] [Full Text] [Related]
19. Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys. Schmitz JE, Lifton MA, Reimann KA, Montefiori DC, Shen L, Racz P, Tenner-Racz K, Ollert MW, Forman MA, Gelman RS, Vogel CW, Letvin NL. AIDS Res Hum Retroviruses; 1999 Jan 20; 15(2):195-202. PubMed ID: 10029251 [Abstract] [Full Text] [Related]
20. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. Pietra BA, Wiseman A, Bolwerk A, Rizeq M, Gill RG. J Clin Invest; 2000 Oct 20; 106(8):1003-10. PubMed ID: 11032860 [Abstract] [Full Text] [Related] Page: [Next] [New Search]